METHODOLOGY

We strive to construct the 3-D model with normal primary (non-transformed) cell lines. The significance of the non-transformed cell is highlighted by Sexton  et al, 2008:
"By utilizing normal (non-immortalized) human tissue,  potential species-related differences which may compromise data evaluation lessens. The full spectrum of pathophysiological effects resulting from in vivo exposure to toxic airway particulates can only be realized in a biological model in which the cell-cell interactions can be fully transcribed and translated by the cellular genetic response to those toxins."

The 3-D cell culture models overcome the inherent problems associated with the traditional 2-D monolayer culture such as the following:

  • Cellular de-differentiation
  • Loss of metabolic functionality

In contrast, 3-D tissue culture technology alleviates these problems:

  • Cells are cultured on beads or fiber platforms, forming  tissue-like organoids
  • Cells assume their native spatial conformation
  • Cell-cell interactions relative to their phenotype characteristics and metabolic functionality

 

The 3-D model assumes the phenotype and functionality of in vivo tissue.


3D Cell Incubator

...the Next Generation of Cell-Tissue Culture

Model Engineering:  Aliquots of frozen cells are thawed and propagated in 2-D cell culture flasks until sufficient numbers are recovered and then infused into a bioreactor. With multiple cell types,  this procedure is repeated until all required cell lines have been infused. The infused cells continue to propagate and develop within the bioreactor to a predetermined time point. At certain points along the developmental timeline, aliquots of cells are removed for quality control of  histology, viability and  apoptosis.   

3 D Cell Tissue Organoids

Advantages of 3-D cell culture technology:

  • Pathogens not currently supported by 2-D cell culture or laboratory animal models
  • Detection and identification of pathogen metabolic pathways
  • Definition of host cell-pathogen receptors
  • Recognition of host cell innate responses
  • Rapid pre-clinical screening of novel therapeutic candidates